Ecor1 Capital, Llc Insider Profile
25 Followers
Ecor1 Capital, Llc, Ten Percent Owner at Atara Biotherapeutics, holds 1.55M shares in Atara Biotherapeutics (Ticker: ATRA), holds 347.31K shares in Aktis Oncology, Inc. (Ticker: AKTS), holds 100.37M shares in Adaptimmune Therapeutics (Ticker: ADAPY). Most recently, Ecor1 Capital, Llc Bought ― shares of Atara Biotherapeutics on May 11, 2026 for an estimated value of $4.74M.
Ecor1 Capital, Llc's Trading History
| ATRAAtara Biotherapeutics | May 11, 2026 | Ten Percent Owner | Informative Buy | 4.74M | $11.95M | |
| AKTSAktis Oncology, Inc. | Jan 12, 2026 | Director | Uninformative Buy | ― | $5.77M | |
| ADAPYAdaptimmune Therapeutics | Jul 30, 2025 | Ten Percent Owner | Informative Sell | 6.74M | $3.01M | |
| ZYMEZymeworks | Jun 27, 2025 | Director, Ten Percent Owner | Uninformative Buy | 521.11 | $602.74M | |
| ITOSiTeos Therapeutics | May 16, 2025 | ― | Informative Buy | 38.68M | $108.49M | |
| PRTAProthena | May 06, 2025 | Ten Percent Owner | Informative Sell | 50.83M | $43.29M | |
| ANABAnaptysBio | Jan 02, 2025 | Director, Ten Percent Owner | Informative Buy | 1.10M | $364.45M | |
| MRSNMersana Therapeutics | Dec 23, 2024 | ― | Uninformative Sell | ― | $329.42M | |
| TNGXTango Therapeutics | Nov 08, 2024 | Ten Percent Owner | Informative Sell | 8.42M | $271.08M | |
| VYGRVoyager Therapeutics | Jan 11, 2023 | Ten Percent Owner | Informative Sell | 7.14M | $6.66M | |
| ODTCOdonate | Dec 10, 2021 | Ten Percent Owner | Informative Sell | 9.74M | $0.00 | |
| CRVSCorvus Pharmaceuticals | Oct 01, 2021 | Ten Percent Owner | Informative Sell | 25.04M | $862.66K | |
| SURFSurface Oncology | Sep 03, 2020 | ― | Informative Sell | 2.38M | $5.03M | |
| AKUSAKOUOS | Jul 02, 2020 | ― | Uninformative Buy | ― | $26.26M | |
| EIGRQEiger Biopharmaceuticals | Jun 30, 2015 | ― | Informative Buy | ― | $24.17M | |
| GNVCGenVec Inc | May 27, 2014 | ― | Informative Buy | 54.04K | $6.92M |
You May Also Like
Ecor1 Capital, Llc insider profile FAQ
What is the percentage of profitable transactions made by Ecor1 Capital, Llc?
The percentage of profitable transactions made by Ecor1 Capital, Llc is 67%.
What is the average return per transaction made by Ecor1 Capital, Llc?
The average return per transaction made by Ecor1 Capital, Llc is 36.10%.
What stocks does Ecor1 Capital, Llc hold?
Ecor1 Capital, Llc holds: ATRA, PRTA, ADAPY, VYGR, CRVS, EIGRQ, ANAB, ZYME, MRSN, ODTC, SURF, AKUS, ITOS, TNGX, AKTS, GNVC stocks.
What was Ecor1 Capital, Llc’s latest transaction?
Ecor1 Capital, Llc’s latest transaction was an Informative Buy of $4.74M.
What was Ecor1 Capital, Llc's most profitable transaction?
Ecor1 Capital, Llc’s most profitable transaction was an Informative Buy of ANAB stock on January 2, 2025. The return on the trade was 236.40%.
What is Ecor1 Capital, Llc's role in Atara Biotherapeutics?
Ecor1 Capital, Llc's role in Atara Biotherapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
